Dose-related patterns of glucocorticoid-induced side effects

Area of Science:

• Rheumatology
• Pharmacology
• Clinical Medicine

Background:

• Rheumatoid arthritis (RA) management often involves glucocorticoids.
• Understanding the real-world adverse effects of glucocorticoids is crucial for patient care.
• Routine practice data provides valuable insights into long-term medication impacts.

Purpose of the Study:

• To investigate the relationship between glucocorticoid dosage and duration and self-reported health problems in RA patients.
• To identify specific adverse event patterns associated with different glucocorticoid intake levels.
• To inform clinical decision-making regarding glucocorticoid therapy in RA.

Main Methods:

• Analysis of data from 1066 unselected RA patients in routine practice.
• Physician-reported clinical status and drug treatment.
• Patient-reported health problems over the past 6 months using a comprehensive symptom list.
• Comparison of patients on long-term glucocorticoid treatment (varying doses) with a non-glucocorticoid group.

Main Results:

• Health problem frequency increased with glucocorticoid dosage.
• Linear dose-related adverse events included cushingoid phenotype, ecchymosis, leg edema, mycosis, parchment skin, shortness of breath, and sleep disturbance.
• Threshold dose-related adverse events (over 7.5 mg/day) included glaucoma, depression, and increased blood pressure.
• Weight gain and epistaxis were linked to 5 mg/day or higher doses.
• Eye cataracts showed a very low threshold (<5 mg/day).

Conclusions:

• Observed adverse event patterns align with known biological mechanisms and clinical findings.
• This study provides essential real-world data on glucocorticoid adverse effects in a broad patient population.
• Findings can assist clinicians in optimizing glucocorticoid therapy to improve the benefit-risk balance for RA patients.